This profile describes access and programme structure. Inclusion is not an endorsement, regulatory finding, or clinical recommendation. Prescription decisions belong to a qualified prescriber.
At a glance
Pricing, medicine, location, care, fulfilment, funding, and policy claims are separated below.
An open check means the public sources were not specific enough—not that the service failed the check.
Resumen en español
Noom Med para usuarios hispanohablantes
Esta sección ofrece una orientación breve en español sobre el perfil estadounidense. La investigación completa de precios, acceso, farmacia y seguimiento permanece arriba mientras ampliamos la revisión editorial en español.
No encontramos una fuente primaria suficientemente específica para afirmar que una cita clínica esté disponible en español. Confirma el idioma y cualquier servicio de interpretación antes de pagar.
- si la cita concreta será en español;
- el coste mensual ordinario y qué incluye;
- la licencia estatal del profesional;
- el medicamento, la farmacia y el coste por separado.
Esta traducción editorial no demuestra que el proveedor ofrezca atención clínica en español y no sustituye una valoración médica.
Comparar proveedores para hispanohablantes en EE. UU. →How the program is structured
A medication-access program integrated with Noom’s behavior-change app, lessons, tracking, and clinical support. Current public marketing spans insurance-assisted brands, cash brand paths, and a microdose program, so the offer selected at checkout matters.
GLP.directory checked the cited public sources on Sep 13, 2026. We reviewed published access, cost, care, fulfilment, funding, cancellation, monitoring, and switching details; we have not audited individual clinical encounters, prescriptions, pharmacy operations, or outcomes.
Availability can change by state, clinician, medical history, product, pharmacy, inventory, and insurance plan. “Not publicly confirmed” means we did not find a sufficiently specific answer in the cited public material. Confirm the current patient-specific answer before paying or changing care.
Service configuration
These structured fields power the directory filters. They describe the reviewed public route and should be reconfirmed for the selected plan.
- Provider type
- Telehealth program
- Medicine context
- Semaglutide (Wegovy; Ozempic/Rybelsus for type 2 diabetes) · Tirzepatide (Zepbound; Mounjaro for type 2 diabetes)
- Formats reviewed
- Injection · Oral medicine
- Funding routes
- Private pay · Insurance support
- Service features
- Coaching · Clinician support · Switching pathway · Home delivery
- Access check
- Confirm current state access
- Evidence status
- Primary sources reviewed
- Research depth
- 2 cited sources · 4 medicine rows · 4 open checks
Recurring cost breakdown
- The brand-medication pathway advertises a program fee from $39 plus the medication’s cash price or copay.
- A microdose program was advertised from $79; formulation, dose, term, and renewal total must be confirmed.
- Behavior curriculum, tracking, and care support are part of the program layer.
- Labs and nonstandard clinical services were not confirmed as universally included.
- Medicine + dose
- Membership or consultation
- Delivery + supplies
- Labs + follow-up
- Renewal after offers
Medication and formulation matrix
| Medication | Form | Regulatory / program path | Published price view |
|---|---|---|---|
| Wegovy | Daily pill or weekly injection | FDA-approved brand | Program fee plus cash price/copay |
| Zepbound | Weekly injection | FDA-approved brand | Program fee plus cash price/copay |
| Ozempic | Weekly injection | FDA-approved for type 2 diabetes | Eligibility and coverage dependent |
| Metformin / microdose GLP-1 pathway | Oral or low-dose program | Product-specific disclosure required | From-price only; confirm full term |
Important: “Compounded” means the product is not FDA approved. A brand approved for one condition is not automatically approved for another. The treating clinician determines whether any prescription is appropriate.
State-by-state availability
- Available through licensed clinicians in supported US states; not every product or fulfillment method is available everywhere.
- No durable public state-by-product table was located.
Clinician access and follow-up cadence
- Noom Med pairs clinician review with app-based communication and behavioral support.
- The public page did not state one guaranteed clinician-visit cadence across every plan.
Pharmacy and fulfillment
- Noom coordinates pharmacy fulfillment; some paths support home delivery while others may use a retail pharmacy.
- The named dispensing pharmacy is product- and state-dependent.
Insurance and prior authorization
- Insurance and cash routes are advertised.
- Prior authorization, formulary choice, deductible, and final copay remain plan-specific.
Cancellation, refund, and commitment
- Cancellation and refund treatment depends on the Noom subscription or medication program purchased.
- The reviewed Med page did not state the complete cancellation rule beside every offer; read the checkout term and general terms before prepaying.
Labs, monitoring, and dose management
- No universal included lab panel or repeat-testing schedule was publicly confirmed.
- Clinical monitoring and dose adjustment depend on the selected medication and patient history.
Maintenance and switching
- An existing prescription does not guarantee continuation at the same product or dose.
- Ask how Noom handles records, prior authorization, and refill timing for a transfer.
Program snapshot
Clinical and behavior program
Profiled support: Ongoing clinician access, Coaching or behavior support.
Cash pay · Insurance help
Noom markets multiple medication routes; confirm whether the selected path uses insurance, direct pay, or an included compounded product.
Verify before purchase
The dispensing pharmacy depends on the prescribed path. Ask for its name and the refill process.
What the advertised program may include
- Clinician access
- Human and AI coaching
- Behavior curriculum
- Food, movement, and progress tools
- Medication when included and prescribed
Useful comparison signals
Based on the provider’s published program structure, this profile is tagged for the following searches. These are filters, not endorsements or clinical recommendations.
- Starting care and comparing first-provider requirements
- Switching providers or continuing an established treatment
- Ongoing clinician access
- Coaching or behavior support
Open evidence gaps
These are material details we could not confirm precisely enough from the cited public pages. They are the highest-priority questions to resolve directly.
- State-by-product availability
- Named pharmacy by route
- Plan-specific clinical cadence
- Complete cancellation rule beside each current offer
Questions to ask before paying
- What is the ordinary recurring total after any introductory period?
- Does that total include clinician care, medication, supplies, labs, and shipping?
- Which clinician group and dispensing pharmacy will be responsible for my care?
- What happens to billing if I am not prescribed the advertised treatment?
- What records and timing do you require if I am switching from another provider?
Source ledger
Every entry below is a provider-controlled or official public source. A source link documents what was published; it does not independently validate performance, regulatory compliance, safety, or outcomes.
Current programs, medications, pricing headlines and support model
Subscription, renewal and cancellation framework